MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
Top Cited Papers
Open Access
- 1 May 2008
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (5), 1600-1608
- https://doi.org/10.1210/jc.2007-2696
Abstract
Objective: MicroRNA (miRNA) expression is deregulated in many types of human cancers. We sought to investigate the expression patterns of miRNA in all major types of thyroid tumors, including tumors carrying distinct oncogenic mutations, and to explore the utility of miRNA profiling for the preoperative diagnosis of thyroid nodules. Design: miRNA expression levels were detected in 60 surgically removed thyroid neoplastic and nonneoplastic samples and in 62 fine-needle aspiration (FNA) samples by RT-PCR using TaqMan MicroRNA Panel or individual miRNA sequence-specific primers. miRNA expression levels were calculated relative to normal thyroid tissue. All tumors were genotyped for most common mutations. Results: Various histopathological types of thyroid tumors, including those deriving from the same cell type, showed significantly different profiles of miRNA expression. Oncocytic tumors, conventional follicular tumors, papillary carcinomas, and medullary carcinomas formed distinct clusters on the unsupervised hierarchical clustering analysis. Significant correlation between miRNA expression patterns and somatic mutations was observed in papillary carcinomas. A set of seven miRNAs (miR-187, miR-221, miR-222, miR-146b, miR-155, miR-224, and miR-197) that were most differentially overexpressed in thyroid tumors vs. hyperplastic nodules in the surgical samples was validated in the FNA samples, showing high accuracy of thyroid cancer detection. Conclusions: In this study, we demonstrate that various histopathological types of thyroid tumors have distinct miRNA profiles, which further differ within the same tumor type, reflecting specific oncogenic mutations. A limited set of miRNAs can be used diagnostically with high accuracy to detect thyroid cancer in the surgical and preoperative FNA samples.Keywords
This publication has 35 references indexed in Scilit:
- Faculty Opinions recommendation of High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.Published by H1 Connect ,2013
- Specific microRNAs are downregulated in human thyroid anaplastic carcinomasOncogene, 2007
- The functions of animal microRNAsNature, 2004
- Detection of BRAF Mutation on Fine Needle Aspiration Biopsy Specimens: A New Diagnostic Tool for Papillary Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2004
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004
- RASPoint Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular CarcinomaJournal of Clinical Endocrinology & Metabolism, 2003
- PAX8-PPARγ Rearrangement in Thyroid TumorsThe American Journal of Surgical Pathology, 2002
- Diagnosis of multiple cancer types by shrunken centroids of gene expressionProceedings of the National Academy of Sciences, 2002
- Prevalence of RET/PTC Rearrangements in Hashimoto's Thyroiditis and Papillary Thyroid CarcinomasInternational Journal of Surgical Pathology, 2002
- Controlling the false discovery rate in behavior genetics researchBehavioural Brain Research, 2001